United States· US:23155-594_9de2927d-27ac-4890-ad71-a737dd4d3881

Amphotericin B

A medicinal product containing amphotericin b, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAmphotericin BATC—REGISTER NO.US:23155-594_9de2927d…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
AMPHOTERICIN B
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    2315559431
    1 VIAL, SINGLE-DOSE in 1 CARTON (23155-594-31) / 1 INJECTABLE, LIPOSOMAL in 1 VIAL, SINGLE-DOSE
  • ndc11
    23155-594-31

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Amphotericin b in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amphotericin b products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Ambisome Liposomal, Ampho-Moronal
  • Belgium · Ambisome Liposomales, Amfotericine B Liposomaal Tillomed
  • Bulgaria · Амфотерицин B Липозомал Тиломед
  • Cyprus · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
  • Czechia · Abelcet Lipid Complex, Amfotericin B Liposomal Tillomed
  • Germany · Ambisome Liposomal, Ampho-Moronal
  • Denmark · Ambisome Liposomal
  • Estonia · Amphotericin B Liposomal Tillomed
  • Spain · Abelcet Complejo Lipídico, Ambisome Liposomal
  • Finland · Ambisome Liposomal, Fungizone
  • France · Ambisome Liposomal, Fungizone
  • United Kingdom (Northern Ireland) · Amphotericin B Liposomal Gilead, Amphotericin B Liposomal Sun Pharma
  • Greece · Ambisome Liposomal
  • Hungary · Abelcet, Ambisome Liposzómás
  • Ireland · Ambisome liposomal, Amphotericin B Liposomal Tillomed
  • Iceland · Ambisome Liposomal
  • Italy · Ambisome Liposomiale, Fungizone
  • Luxembourg · Abelcet Lipid Complex, Ambisome Liposomales
  • Latvia · Ambisome liposomāls, Amphotericin B Tillomed
  • Malta · Ambisome Liposomal
  • Netherlands · Ambisome liposomale, Amfotericine B Liposomaal Tillomed
  • Norway · Ambisome Liposomal
  • Poland · Abelcet, Ambisome Liposomal
  • Portugal · Abelcet, Ambisome Lipossomal
  • Romania · Ambisome liposomal, Amfotericină B Lipozomală Tillomed
  • Sweden · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
  • Slovenia · Ambisome Liposomal, Amfotericin B Liposomal Tillomed
  • Slovakia · Abelcet Lipid Complex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abbbd2e5-9915-4ed3-9f98-f8a07cc8881d
GET /v1/drugs/abbbd2e5-9915-4ed3-9f98-f8a07cc8881d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "50",
  "substance": "AMPHOTERICIN B",
  "productndc": "23155-594",
  "dosage_form": "INJECTABLE, LIPOSOMAL",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA215354",
  "marketing_category": "ANDA"
}

See everything about amphotericin b.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.